Related Experiment Video
Updated: Aug 1, 2025

Author Spotlight: A Model to Study the Systemic and Local Dynamics of CD8+ T Cells During LN Metastasis
Published on: January 26, 2024
Optimal cancer evasion in a dynamic immune microenvironment generates diverse post-escape tumor antigenicity profiles
Jason T George1,2,3, Herbert Levine3,4,5
1Department of Biomedical Engineering, Texas A&M University, Houston, United States.
Abstract:
The failure of cancer treatments, including immunotherapy, continues to be a major obstacle in preventing durable remission. This failure often results from tumor evolution, both genotypic and phenotypic, away from sensitive cell states. Here, we propose a mathematical framework for studying the dynamics of adaptive immune evasion that tracks the number of tumor-associated antigens available for immune targeting. We solve for the unique optimal cancer evasion strategy using stochastic dynamic programming and demonstrate that this policy results in increased cancer evasion rates compared to a passive, fixed strategy. Our foundational model relates the likelihood and temporal dynamics of cancer evasion to features of the immune microenvironment, where tumor immunogenicity reflects a balance between cancer adaptation and host recognition. In contrast with a passive strategy, optimally adaptive evaders navigating varying selective environments result in substantially heterogeneous post-escape tumor antigenicity, giving rise to immunogenically hot and cold tumors.
Insights
Cancer treatments often fail due to tumor evolution. This study introduces a mathematical model for adaptive immune evasion, showing optimal strategies increase evasion rates and lead to diverse tumor antigenicity.
Area of Science:
- Oncology
- Immunology
- Mathematical Biology
Background:
- Cancer treatment failure, particularly with immunotherapy, is a significant clinical challenge.
- Tumor evolution, encompassing genotypic and phenotypic changes, drives resistance to therapies.
- Understanding tumor adaptation and immune evasion is crucial for developing effective cancer treatments.
Purpose of the Study:
- To develop a mathematical framework for analyzing adaptive immune evasion dynamics in cancer.
- To identify the optimal cancer evasion strategy using computational methods.
- To investigate the relationship between immune microenvironment features and cancer evasion.
Main Methods:
- Utilized stochastic dynamic programming to solve for the optimal cancer evasion strategy.
- Developed a mathematical model tracking tumor-associated antigens available for immune targeting.
- Analyzed the dynamics of adaptive immune evasion in varying selective environments.
Main Results:
- The optimal adaptive cancer evasion strategy significantly increases evasion rates compared to passive strategies.
- Tumor immunogenicity is shown to be a balance between cancer adaptation and host immune recognition.
- Adaptive evaders navigating diverse selective pressures result in heterogeneous post-escape tumor antigenicity, creating 'hot' and 'cold' tumors.
Conclusions:
- Adaptive immune evasion is a key factor in cancer treatment failure.
- Mathematical modeling provides insights into optimal cancer evasion strategies and their impact on tumor immunogenicity.
- The study highlights the heterogeneity of tumor antigenicity following immune escape, influencing treatment response.
Related Concept Videos
Adaptive Mechanisms in Cancer Cells
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
The Tumor Microenvironment
Tumor Immunotherapy
Treatment Resistant Cancers
Cancer Stem Cells and Tumor Maintenance
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Cytotoxic T Cells-mediated Immune Response
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...

